News 2 Nov 2026 Project to develop dengue treatment pre-selected by the Global Coalition for Local and Regional Production, Innovation, and Equitable Access
Press releases 29 Oct 2026 DNDi welcomes GHIT Fund’s support for innovative approaches to improve success in Chagas disease drug discovery with Nagasaki University, the University of Dundee, and Eisai
Scientific articles 27 Oct 2026 Strengthening health systems and clinical development capacities through effective partnerships: a case study of DNDi’s collaboration with the Leishmaniasis Research and Treatment Center in Ethiopia (2003–2022) Frontiers in Tropical Diseases
Scientific articles 26 Oct 2026 Efficacy and safety of oxfendazole in adults with Trichuris spp. infection in Pemba Island, Tanzania: a double-blind, phase 2a, randomised controlled trial eClinicalMedicine
Scientific articles 22 Oct 2026 Deconvoluting the mode of action of antileishmanial aminopyrazoles through chemical mutagenesis Nature communications
Scientific articles 10 Oct 2026 Rethinking Clinical Trial Design to Accelerate Therapeutics for Arboviral Epidemics Open Forum Infectious Diseases
News 9 Oct 2026 DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness
Scientific articles 9 Oct 2026 A Perspective on Biomarkers, Candidates for Surrogate End Points to Accelerate Successful Development of New Antiparasitic Agents for the Treatment of Chronic Chagas Disease ACS Infectious Diseases
Press releases 6 Oct 2026 Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa
Scientific articles 5 Oct 2026 Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesiense PLoS Neglected Tropical Diseases
Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
Scientific articles 22 Sep 2026 Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial The Lancet Infectious Diseases
Scientific articles 19 Sep 2026 Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial BMC Medicine
Press releases 3 Jun 2015 Child-friendly formulation of WHO-recommended treatment now approved by the US FDA for children living with HIV
Press releases 28 May 2015 DNDi and four pharmaceutical companies announce ‘Drug Discovery Booster’ experiment to accelerate and expand discovery of new drugs for two highly neglected diseases – leishmaniasis and Chagas disease
Press releases 11 May 2015 MSF and DNDi Join call for a biomedical research and development fund and mechanism to meet pressing global health needs
Press releases 23 Apr 2015 Ministry of Health and partners disclose recommendations to overcome barriers to access to diagnosis and treatment for Chagas Disease in Colombia
Press releases 16 Dec 2014 DNDi receives US$ 10 million from USAID to develop new drugs for neglected filaria patients
Press releases 9 Dec 2014 Bayer and DNDi sign first agreement to develop an innovative oral treatment for human river blindness
Press releases 1 Dec 2014 World AIDS Day 2014: DNDi welcomes new Medicines Patent Pool licensing agreement and joins PEPFAR, Global Fund, PHTI commitment to reduce HIV treatment gap for HIV-positive children
Press releases 25 Nov 2014 Patient access to miltefosine in developing countries not secure despite award of US FDA PRV sold for USD 125 million
Press releases 25 Nov 2014 Strategic collaboration for developing urgent innovative therapies for neglected diseases in Latin America
Press releases 4 Nov 2014 Artesunate-Mefloquine Fixed-Dose Combination (ASMQ FDC) Proves Safe and Efficacious to Treat Children in Africa with Malaria
Press releases 2 Nov 2014 DNDi Receives USD 60 Million to Fill Research and Development Gaps for Neglected Patients
Press releases 15 Oct 2014 Study Results Support WHO Recommendations for Safe and Effective Kala-azar Treatments in Bangladesh
Press releases 6 Oct 2014 Phase III Clinical Study in Ethiopia Launched to Test Two Treatments for HIV-Visceral Leishmaniasis Co-infected Patients
Press releases 1 Oct 2014 Results of Large-Scale Roll Out of Combination Treatment for Kala-Azar in Eastern Africa Points to Urgency to Treat Disease Victims as Outbreak Surges in South Sudan
Press releases 24 Sep 2014 Celgene Global Health and DNDi Expand Collaboration to Identify Innovative Therapies to Benefit Patients with Neglected Tropical Diseases
